CLINICAL_TRIALS
trial_result
· 2021-11-26
Clinical Trial Update: Study to Evaluate Tezepelumab in Adults & Adolescents With Severe Uncontrolled Asthma [Phase 3]
Summary
Phase 3 trial evaluating tezepelumab in adults and adolescents with severe uncontrolled asthma completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2021-11-26